FiercePharma1h
Aragen snares $100M investment from Quadria Capital to expand its operations
Contract research, manufacturing and development firm Aragen has hauled in a $100 million investment from the private equity ...
FiercePharma9h
JPM25, Day 1: Pfizer CEO discusses plan to overcome $17B 'LOE wave'
Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...
FiercePharma12h
JPM25: After BridgeBio touts 'remarkable' early uptake for its Vyndaqel rival, analysts hail Attruby's debut as a 'launch to own'
Less than two months after scoring what analysts deemed a "best-case" FDA approval for its cardiomyopathy drug Attruby, ...
FiercePharma22h
JPM25: Moderna slashes guidance, plots $1B in cost cuts this year amid lackluster vaccine sales
Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...
FiercePharma23h
JPM25: Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B
At $132 per share, J&J paid a 39% premium on Friday’s closing price of Intra-Cellular, a New York City based biotech that ...
FiercePharma21h
Endo delivers more straight talk in fresh TV spot to bust Peyronie’s taboo
What connects a broken windshield, a raccoon infestation and Peyronie’s disease? | What connects a broken windshield, a ...